Article History
Received: 14 July 2020
Accepted: 13 August 2020
First Online: 1 December 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: K.E. and S.N. has submitted patents related to some references [, , , , , ]. K.E. is a cofounder of Megakaryon Corporation and a member of its scientific advisory board without salary. K.E. receives grants from Megakaryon, Otsuka Pharmaceutical Co., Ltd., and Kyoto Seisakusho Co., Ltd. The interests of K.E. were reviewed and are managed by Kyoto University in accordance with its conflict of interest policies. S.N. and N.S. declare no conflict of interest.